Today: 8 June 2026
Macquarie stock pops on Q3 update, then cools — what MQG investors are watching next
10 February 2026
2 mins read

Macquarie stock pops on Q3 update, then cools — what MQG investors are watching next

Sydney, February 10, 2026, 16:44 (AEDT) — The session wrapped up with the market now closed.

  • Macquarie shares ended up after the third-quarter trading update, having surged roughly 4% at the open.
  • Asset management and commodities set the pace. Mortgage growth held up, though margins are still squeezed.
  • Attention is turning to the tax-rate outlook, with May’s full-year result now in focus.

Shares of Macquarie Group Ltd (ASX: MQG) finished Tuesday’s session 0.8% higher at A$214.50, trimming gains after a strong jump earlier in the day. The stock reached as high as A$221.32 before late selling took the edge off, following news from the company that trading in the December quarter remained steady.

Timing’s key here. Macquarie stands out among Australian financials, with a sizable slice of profits tied to markets — think performance fees, asset disposals, commodities trading. Those lines can turn fast if the backdrop shifts.

It’s one of the rare straightforward looks at the market ahead of the March year-end. Macquarie skips a full group quarterly profit number, leaving investors to pore over the divisional “net profit contribution”—that’s a management metric, backing out tax and a handful of corporate line items. Anything management offers as a short-term indicator also gets close attention.

All four of Macquarie’s operating groups posted higher net profit contributions for the quarter ended Dec. 31 versus a year ago, with Macquarie Asset Management getting a boost from selling off its North American and European public investments business. Assets under management climbed 3% from September to A$736.1 billion, while the banking business saw a 6% jump in deposits to A$204.5 billion and a 7% rise in its home loan book, now at A$172.2 billion. Macquarie Capital flagged its A$28.9 billion private credit book. The group finished the period with an A$7.5 billion capital surplus above regulatory minimums. CEO Shemara Wikramanayake described Macquarie as “well-positioned to deliver superior performance in the medium term”. Macquarie

The S&P/ASX 200 barely budged, slipping just 0.03% to 8,867.40. Traders zeroed in on individual names like MQG for most of the action.

Traders zeroed in on the numbers that move the shares: Macquarie’s short-term indicators suggested investment-driven income at Macquarie Capital is up, “net other operating income” at Macquarie Asset Management jumped sharply, and commodities income in Commodities and Global Markets is also climbing. The stock spiked as much as 4%—biggest single-day jump since mid-October. UBS called the core numbers “strong,” though noted Macquarie’s warning about a higher effective tax rate for 2026, now seen around 31%, took some shine off. Citi didn’t expect the update to move the needle on FY26 forecasts. Reuters

The banking segment doesn’t make much noise, but it’s far from minor. Macquarie keeps advancing into Australia’s mortgage market, an arena where the big four — Commonwealth Bank, Westpac, National Australia Bank, and ANZ — steer both pricing and margins.

The upside, though, is hardly a straight path. Performance fees and asset realisations often show up in lumps, while income from commodities trading drops off when volatility settles down. The bank’s flagged risks: tax shifts, new rules, and currency swings—all of which can throw near-term numbers off course.

Looking ahead, dealers are watching to see if the stock manages to keep its gains from the post-briefing rally, with brokers now factoring in the effective tax rate that management flagged. Another focus: is the jump in commodities income sustainable, or was this quarter just a lucky one-off?

Macquarie’s investor calendar shows the full-year results are set for release on Friday, May 8, 2026. Shares are slated to go ex-dividend the following Monday, May 18.

Stock Market Today

  • Indian Stock Market July 8: Cautious Start Amid Middle East Tensions
    June 8, 2026, 9:21 AM EDT. Indian stocks are poised for a cautious open on June 8, impacted by rising Middle East tensions and a global market selloff. The GIFT Nifty index fell over 1%, as Asian markets including South Korea and Japan declined sharply, signaling increased investor risk aversion. Higher crude oil prices and a rebound in gold indicate a shift towards defensive assets. Investors will watch key domestic developments in companies like TVS Motor, RailTel, KNR Constructions, Creative Newtech, Amber Enterprises, and Ixigo. Fundraising activities at Zee, ASM Technologies, and Gujarat Themis, along with regulatory issues at Yes Bank, 5Paisa, and Reliance Infrastructure, will also remain in focus.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Silver price jumps again as dollar slips — here’s what traders watch next
Previous Story

Silver price jumps again as dollar slips — here’s what traders watch next

BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results
Next Story

BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results

Go toTop